Stocks and Investing
Stocks and Investing
Thu, December 19, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mike Matson Downgraded (BSX) to Strong Buy on, Dec 19th, 2019
Mike Matson of Needham, Downgraded "Boston Scientific Corporation" (BSX) to Strong Buy on, Dec 19th, 2019.
Mike has made no other calls on BSX in the last 4 months.
There are 4 other peers that have a rating on BSX. Out of the 4 peers that are also analyzing BSX, 0 agree with Mike's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Mike
- Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $51 on, Tuesday, December 17th, 2019
- Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $52 on, Monday, December 16th, 2019
- Jayson Bedford of "Raymond James" Maintained at Strong Buy with Decreased Target to $48 on, Monday, October 14th, 2019
- Travis Steed of "Barclays" Initiated at Buy and Held Target at $48 on, Tuesday, September 3rd, 2019
Contributing Sources